Aggrenox
Product Images NDC 21695-656

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aggrenox (NDC 21695-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Dipyridamole. (6473563d B4df 4434 A74e F8fa3cb9994f 01)

Structural Formula Of Dipyridamole. (6473563d B4df 4434 A74e F8fa3cb9994f 01)
This text appears to be describing a chemical compound with the molecular formula "CaaHagNz04" and a molecular weight of 50463. However, the formula is not recognized and may be the result of a scanning error. *
FDA Label Image

Structural Formula Of Benzoic Acid. (6473563d B4df 4434 A74e F8fa3cb9994f 02)

FDA Label Image

Figure 1. (6473563d B4df 4434 A74e F8fa3cb9994f 03)

FDA Label Image

Aggrenox 25mg/200mg Label (6473563d B4df 4434 A74e F8fa3cb9994f 04)

Aggrenox 25mg/200mg Label (6473563d B4df 4434 A74e F8fa3cb9994f 04)
Aggrenox 25mg/200mg is a prescription drug manufactured by Boehringer Ingelheim Pharmaceuticals. It comes in a bottle that contains 60 extended-release capsules with alternating red and light ivory-colored bodies. Each capsule contains two active ingredients - Dipyridamole E.R. 25mg and Aspirin 200mg. Aggrenox is used to reduce the risk of stroke in people who have had transient ischemic attacks or completed ischemic strokes. The drug should be stored at controlled room temperature, kept out of reach of children, and is available only by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.